Article Text
PDFReviews
Congenital myasthenic syndromes: an update
Statistics from Altmetric.com
Footnotes
-
Contributors All authors contributed to the drafting and writing of this article. SF takes responsibility for the overall content.
-
Funding No specific funding was received for this paper, though we acknowledge the work was made possible by funding of the CMS service by the National Commissioning Group.
-
Competing interests None.
-
Patient consent Obtained.
-
Provenance and peer review Commissioned. Externally peer reviewed. This paper was reviewed by Georgina Burke, Southampton, UK.
Read the full text or download the PDF:
Other content recommended for you
- Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
- Myasthenia and related disorders of the neuromuscular junction
- Congenital myasthenic syndromes
- Clinical features of the myasthenic syndrome arising from mutations in GMPPB
- Congenital familial myasthenic syndromes: disease and course in an affected dizygotic twin pair
- Update on myasthenia gravis
- Novel ϵ subunit mutation of the muscle acetylcholine receptor causing a slow-channel congenital myasthenic syndrome
- A ‘limb-girdle muscular dystrophy’ responsive to asthma therapy
- An ocular motility conundrum
- An Iranian family with congenital myasthenic syndrome caused by a novel acetylcholine receptor mutation (CHRNE K171X)